How to Get Alprostadil (Caverject/MUSE) in Utah

What Alprostadil Is and Why It Matters for Utah Patients

Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes cavernosal smooth muscle and dilates penile arterial blood flow, producing an erection within 5 to 20 minutes of administration. The drug is FDA-approved in two delivery systems: Caverject (intracavernosal injection) and MUSE (medicated urethral system for erection, a urethral suppository). Both are prescription-only.

The 1996 Linet et al. landmark trial published in the New England Journal of Medicine (N=296) reported that 94.8% of injections with alprostadil produced a clinically sufficient erection for intercourse compared with 13.7% of placebo injections (P<0.001) [1]. That evidence base is the reason alprostadil remains the gold-standard second-line option after PDE5 inhibitor failure.

In Utah, roughly 1 in 10 men over age 40 report moderate-to-severe erectile dysfunction, consistent with the national prevalence data published by the National Institutes of Health [2]. PDE5 inhibitors (sildenafil, tadalafil) are tried first in most cases. When those fail because of contraindications, insufficient response, or post-prostatectomy nerve damage, alprostadil becomes the primary pharmacologic option.

The FDA approved Caverject in 1995 and MUSE in 1997 [3]. Both remain on the FDA's list of approved prescription drugs, and neither is classified as a controlled substance under Utah or federal law [4]. That classification simplifies the prescribing pathway considerably compared to testosterone or opioids.

How to Get an Alprostadil Prescription in Utah

Getting a prescription requires a licensed Utah prescriber to evaluate your history, confirm the diagnosis of erectile dysfunction, rule out contraindications, and train you on injection or suppository technique. There are three practical routes in Utah.

Route 1: In-person urology appointment. Board-certified urologists at University of Utah Health, Intermountain Health, and private practices across Salt Lake City, Provo, and St. George can prescribe alprostadil after a standard office evaluation. Expect a 30 to 60 minute new-patient visit. The provider will typically perform a focused genitourinary exam, review vascular and neurologic history, and conduct an in-office test injection at a starting dose (commonly 2.5 mcg for neurogenic ED or 5 mcg for vasculogenic ED) [5].

Route 2: Telehealth. Utah permits telehealth prescribing for erectile dysfunction under state law [6]. A provider conducting a synchronous audio-visual encounter may issue an alprostadil prescription if they can clinically evaluate the patient, document a valid patient-provider relationship, and arrange for in-person or video-supervised first-dose training. The American Urological Association's 2018 guideline on erectile dysfunction notes that "the goal of treatment is to restore satisfactory sexual activity" and does not restrict the prescribing modality to in-person visits [7].

Route 3: HealthRX telehealth. HealthRX providers licensed in Utah conduct synchronous video consultations, review intake labs and medical history, and, when appropriate, issue alprostadil prescriptions routed to a licensed Utah or mail-order pharmacy. The first-dose training is completed via video with the provider reviewing injection landmarks in real time.

Regardless of route, expect the prescriber to ask about cardiovascular status, anticoagulant use (alprostadil combined with warfarin or heparin increases bleeding risk at the injection site), penile anatomical abnormalities such as Peyronie's disease, and prior PDE5 inhibitor trials [8].

What Labs Are Required Before Starting Alprostadil

No single universal lab panel is mandated by FDA labeling for alprostadil [3], but evidence-based practice guidelines suggest baseline testing to exclude systemic causes and to document cardiovascular safety before any ED treatment.

The American Urological Association's 2018 ED guideline recommends fasting glucose or HbA1c and a fasting lipid panel as minimum baseline metabolic labs [7]. The Endocrine Society's 2018 testosterone guideline also advises a morning total testosterone (drawn between 7 a.m. and 10 a.m.) to rule out hypogonadism as a reversible cause of ED [9]. A complete blood count is prudent when anticoagulant therapy is a concern.

Specific lab requirements for Utah HealthRX consultations include:

• Fasting glucose or HbA1c (within 12 months)
• Fasting lipid panel (within 12 months)
• Morning total testosterone (within 6 months)
• PSA if the patient is over 40 and testosterone replacement may follow

If all of these were drawn by a primary care provider within the past year, you can upload those results during your HealthRX intake. No repeated blood draw is needed [10].

Vascular testing such as penile Doppler ultrasound is not required before starting alprostadil. It is typically reserved for patients who fail a 6-injection trial or in whom a surgically correctable vascular lesion is suspected [7].

Telehealth Providers in Utah Prescribing Alprostadil

Utah's telehealth statutes (Utah Code Ann. § 26B-4-201) permit any licensed prescriber to issue a prescription following a synchronous audio-video encounter, provided the standard of care for that clinical decision can be met remotely [6]. Alprostadil for confirmed erectile dysfunction meets that threshold for most patients, with the practical caveat that first-dose supervision must be arranged.

HealthRX operates fully within these rules. After a 20 to 30 minute intake video visit, the provider reviews your medical history, uploaded labs, and medication list. If alprostadil is appropriate, the prescription is sent electronically to a licensed Utah pharmacy or to an accredited mail-order pharmacy serving Utah.

Other telehealth platforms operating in Utah include general men's health services affiliated with national chains. Patients should confirm that the prescribing provider holds an active Utah medical, DO, NP, or PA license before completing a consultation, because out-of-state telehealth prescribers without Utah licensure cannot legally issue Utah prescriptions [6].

Nurse practitioners (NPs) and physician assistants (PAs) in Utah hold full prescribing authority for non-controlled substances including alprostadil under Utah Code Ann. § 58-31b-803 for NPs and § 58-70a-501 for PAs [11]. There is no statutory requirement for physician co-signature for alprostadil prescriptions issued by licensed NPs or PAs in Utah.

Alprostadil Pharmacies in Utah: Retail, Mail-Order, and 503A Compounding

Once you have a valid prescription, three types of pharmacies serve Utah patients.

Retail pharmacies. Major chains including Smith's (Kroger), Costco Pharmacy, and independent compounding pharmacies in Salt Lake City and Provo stock or can order branded Caverject Impulse kits (10 mcg and 20 mcg) and MUSE suppositories (125 mcg, 250 mcg, 500 mcg, 1 to 000 mcg). Prices without insurance range from approximately $75, $150 per Caverject single-dose kit to $300, $600 for a pack of six MUSE suppositories, based on 2024 GoodRx Utah pricing data.

Mail-order pharmacies. Accredited mail-order pharmacies licensed to ship into Utah can fill both branded and generic alprostadil prescriptions. Delivery typically takes 2, 5 business days after prescription verification. Generic alprostadil injection (Edex or generic) may cost 30 to 50% less than branded Caverject at mail-order volume [12].

503A compounding pharmacies. Utah's pharmacy board licenses 503A compounding pharmacies to prepare patient-specific formulations of alprostadil. A licensed Utah 503A pharmacy may compound alprostadil injection in custom concentrations (for example, 20 mcg/mL or 40 mcg/mL) or as part of a combination formula such as trimix (alprostadil + papaverine + phentolamine) when a prescriber documents a clinical rationale for compounding over a commercially available product [13]. The FDA's guidance on 503A compounding states that compounded drugs must be prepared for an identified individual patient under a valid prescription [4].

Trimix is not FDA-approved as a finished drug product, so it is available only through 503A compounding. Some patients with vasculogenic ED prefer trimix because lower doses of each component may produce an adequate erection with fewer side effects. A prescriber can specify trimix on the same telehealth prescription workflow used for alprostadil alone.

Dosing: What to Expect from Caverject vs. MUSE

Dosing is titrated individually. Both forms require an initial dose-titration phase under medical supervision to identify the lowest effective dose and to observe for adverse effects including prolonged erection (priapism).

Caverject (intracavernosal injection). The FDA-approved starting dose is 2.5 mcg for neurogenic erectile dysfunction and 5 mcg for vasculogenic or mixed erectile dysfunction [3]. The dose is increased by 2.5 to 5 mcg increments at separate office (or supervised telehealth) visits until a firm erection lasting no longer than 60 minutes is achieved. The maximum recommended single dose is 40 mcg. Patients self-inject into the lateral aspect of the proximal third of the penis using a 27, 30 gauge, 0.5-inch needle. Erection onset is typically 5 to 20 minutes; duration is 30 to 60 minutes [1].

MUSE (urethral suppository). The FDA-approved starting dose is 125 mcg or 250 mcg. Patients urinate before administration to moisten the urethra, insert the applicator approximately 3.2 cm into the urethra, and deposit the pellet. Standing or walking for 10 minutes after administration improves absorption. Effective doses in clinical practice range from 500, 1 to 000 mcg; only about 30 to 40% of men achieve a rigidity sufficient for intercourse with MUSE compared to roughly 70% with intracavernosal injection [14]. MUSE is generally preferred by patients who cannot tolerate needles.

The prescriber sets the frequency limit at a maximum of one dose per 24 hours and no more than three doses per week [3]. Exceeding these limits increases the risk of fibrosis at the injection site.

Prior Authorization in Utah: What Documentation Is Required

Utah Medicaid does not cover alprostadil for erectile dysfunction [15]. Commercial insurance plans vary widely. Prior authorization (PA) for commercial plans typically requires the following documentation:

1. A written diagnosis of erectile dysfunction with ICD-10 code N52.xx specified.
2. Documentation of an adequate trial of at least one oral PDE5 inhibitor (sildenafil, tadalafil, vardenafil, or avanafil) at an appropriate dose, unless contraindicated.
3. A contraindication to PDE5 inhibitors if that trial was not completed (for example, concurrent nitrate therapy, documented hypotension, or post-prostatectomy status with nerve-sparing failure).
4. The prescriber's NPI number and Utah DEA registration (even though alprostadil is non-controlled, many PA systems require the DEA field).
5. A letter of medical necessity if the plan requires step therapy beyond two PDE5 inhibitors.

The AUA guideline states: "PDE5 inhibitors are recommended as first-line therapy for erectile dysfunction in men without contraindications. Second-line therapies including intracavernosal injection and intraurethral therapy are recommended when PDE5 inhibitors fail or are contraindicated" [7]. That quotation, or a similar paraphrase from the treating provider, often satisfies the letter-of-medical-necessity requirement.

PA approval typically takes 3, 7 business days for commercial plans. Expedited review (72 hours) is available when the prescriber documents clinical urgency. Your HealthRX provider prepares the PA documentation as part of the consultation workflow.

Transferring an Existing Alprostadil Prescription to Utah

Prescriptions issued in another U.S. state can be transferred to a Utah pharmacy provided the prescription was written by a licensed prescriber in the state of origin and complies with Utah pharmacy law. Because alprostadil is not a controlled substance, there are no DEA transfer restrictions [4]. A retail pharmacy can accept a written, faxed, or electronic transfer. Mail-order pharmacies accept electronic transfer from most states within 24 to 48 hours.

If your out-of-state prescriber is not licensed in Utah, that prescription remains valid for dispensing at a Utah retail pharmacy as long as the prescription itself is valid (not expired, not for a controlled substance) [16]. You do not need a new prescription solely because you moved to Utah.

If your dose needs adjustment or your prescription has expired, a new Utah telehealth consultation with a HealthRX provider takes approximately 20 to 30 minutes and results in a fresh Utah-issued prescription routed directly to your pharmacy of choice.

How Long Does It Take to Receive Alprostadil in Utah

The timeline from first contact to drug in hand depends on the pathway.

Telehealth consultation followed by an in-state retail pharmacy fill takes 1, 3 business days total: roughly same-day or next-day prescription issuance after the video visit, plus 0 to 1 day for pharmacy processing if the drug is in stock.

Mail-order pharmacy delivery adds 2, 5 business days for shipping after prescription verification. Expedited overnight shipping is available at additional cost from most accredited mail-order pharmacies serving Utah.

503A compounded formulations such as trimix take 3, 7 business days because the pharmacy must prepare the formulation after receiving the prescription [13].

If prior authorization is required by commercial insurance, the total wait extends by 3, 7 business days for standard PA review, meaning some patients receive the drug 7, 12 business days after the initial consultation.

The HealthRX Utah Access Framework for alprostadil routes patients through a decision tree: telehealth intake (day 0), lab review and PA filing if needed (days 1, 2), prescription transmission to selected pharmacy (day 2), first-dose video training (day 2, 3), and drug receipt (days 3, 12 depending on pharmacy type and insurance pathway). This structured sequence reduces the average time-to-first-dose for HealthRX Utah patients compared to the traditional urology referral pathway, which carries a median new-patient wait time of 18 to 30 days in Utah metropolitan areas [17].

Safety Considerations: Priapism, Fibrosis, and Cardiovascular Risk

Alprostadil is generally well tolerated, but three safety concerns require patient education before the first dose.

Priapism. An erection lasting more than 4 hours is a medical emergency. The Linet trial reported priapism in 1% of alprostadil-treated patients at titrated doses [1]. Patients must be instructed to go to an emergency department if the erection persists beyond 4 hours. Ice packs and walking are not substitutes for emergency treatment. An injection of phenylephrine (100 to 500 mcg intracavernosal) is the first-line intervention in the ED [7]. Utah's major emergency departments (University of Utah Hospital, Intermountain Medical Center) are equipped to manage priapism.

Corporal fibrosis. Repeated intracavernosal injection causes fibrosis in approximately 5 to 8% of patients with long-term use [18]. Patients should rotate injection sites, use the smallest effective dose, and report any penile nodules or curvature changes to their provider promptly.

Cardiovascular safety. Alprostadil produces mild systemic vasodilation. Blood pressure decreases of 5 to 10 mmHg have been observed in clinical trials [3]. This is rarely clinically significant in otherwise healthy men, but caution is warranted in patients with baseline hypotension (<90/60 mmHg), severe aortic stenosis, or active heart failure. Unlike PDE5 inhibitors, alprostadil does not potentiate the hypotensive effect of nitrates, so it is a viable option for patients on isosorbide mononitrate or nitroglycerin [8].

Penile pain. The most common adverse effect of Caverject is penile pain at the injection site, reported by up to 37% of patients in clinical trials [1]. Pain is usually mild, transient, and decreases with dose optimization. MUSE causes urethral burning in approximately 12% of users [14].

Utah-Specific Regulatory and Insurance Notes

Utah's controlled substance database (CSSD) does not track alprostadil prescriptions because the drug is not scheduled [16]. Prescribers do not need to query the PDMP before issuing an alprostadil prescription in Utah. This simplifies the prescribing workflow compared to testosterone or other monitored medications.

The Utah Insurance Department requires that commercial plans offering prescription drug coverage comply with mental health parity rules, but erectile dysfunction drugs are explicitly excluded from parity protections under the Mental Health Parity and Addiction Equity Act [19]. Patients with Blue Cross Blue Shield of Utah, SelectHealth, or Regence BlueCross BlueShield of Utah should check their specific formulary, as coverage status varies by plan tier and employer group.

Medicare Part D plans cover alprostadil on some formularies, but the Medicare Prescription Drug Benefit statute excludes drugs used exclusively for sexual dysfunction from standard Part D coverage [20]. Medicare Advantage (Part C) plans may cover alprostadil at plan discretion; verification with the individual plan is required before assuming coverage.